A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT02998528 · COMPLETED
Trial details
- NCT number
- NCT02998528
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-04
- Primary completion
- 2021-09-08
- Enrollment
- 505
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.